Annual Operating Expenses
$77.15 M
+$1.95 M+2.59%
31 December 2023
Summary:
ProShares UltraPro Short Nasdaq Biotechnology annual total operating expenses is currently $77.15 million, with the most recent change of +$1.95 million (+2.59%) on 31 December 2023. ZBIO annual operating expenses is now at all-time high.ZBIO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$40.98 M
+$1.28 M+3.23%
30 September 2024
Summary:
ProShares UltraPro Short Nasdaq Biotechnology quarterly total operating expenses is currently $40.98 million, with the most recent change of +$1.28 million (+3.23%) on 30 September 2024. Over the past year, it has increased by +$26.61 million (+185.09%). ZBIO quarterly operating expenses is now at all-time high.ZBIO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZBIO Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.6% | +185.1% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
ZBIO Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +2.6% | at high | +185.1% |
| 5 y | 5 years | at high | +2.6% | at high | +185.1% |
| alltime | all time | at high | +2.6% | at high | +185.1% |
ProShares UltraPro Short Nasdaq Biotechnology Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $40.98 M(+3.2%) |
| June 2024 | - | $39.70 M(+44.0%) |
| Mar 2024 | - | $27.58 M(+11.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $77.15 M(+2.6%) | $24.78 M(+72.4%) |
| Sept 2023 | - | $14.38 M |
| Dec 2022 | $75.20 M | - |
FAQ
- What is ProShares UltraPro Short Nasdaq Biotechnology annual total operating expenses?
- What is the all time high annual operating expenses for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology annual operating expenses year-on-year change?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly total operating expenses?
- What is the all time high quarterly operating expenses for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly operating expenses year-on-year change?
What is ProShares UltraPro Short Nasdaq Biotechnology annual total operating expenses?
The current annual operating expenses of ZBIO is $77.15 M
What is the all time high annual operating expenses for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high annual total operating expenses is $77.15 M
What is ProShares UltraPro Short Nasdaq Biotechnology annual operating expenses year-on-year change?
Over the past year, ZBIO annual total operating expenses has changed by +$1.95 M (+2.59%)
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly total operating expenses?
The current quarterly operating expenses of ZBIO is $40.98 M
What is the all time high quarterly operating expenses for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high quarterly total operating expenses is $40.98 M
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly operating expenses year-on-year change?
Over the past year, ZBIO quarterly total operating expenses has changed by +$26.61 M (+185.09%)